Foundation research

Johnson & Johnson (NYSE:JNJ) shares bought by First Foundation Advisors


First Foundation Advisors increased its position in Johnson & Johnson (NYSE:JNJGet a rating) by 1.5% in the first quarter, according to its latest filing with the Securities and Exchange Commission. The fund held 31,542 shares of the company after acquiring 477 additional shares during the quarter. First Foundation Advisors’ holdings in Johnson & Johnson were worth $5,590,000 when it last filed with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently increased or reduced their stakes in the company. Zevin Asset Management LLC increased its stake in Johnson & Johnson shares by 2.1% in the first quarter. Zevin Asset Management LLC now owns 3,281 shares of the company worth $581,000 after buying 69 additional shares in the last quarter. EFG Asset Management Americas Corp. increased its position in Johnson & Johnson shares by 1.2% during the first quarter. EFG Asset Management Americas Corp. now owns 9,446 shares of the company worth $1,674,000 after acquiring 108 additional shares in the last quarter. S&CO Inc. increased its position in Johnson & Johnson shares by 1.3% during the first quarter. S&CO Inc. now owns 207,976 shares of the company worth $36,859,000 after acquiring 2,725 additional shares in the last quarter. Principal Street Partners LLC increased its position in Johnson & Johnson shares by 4.7% during the first quarter. Principal Street Partners LLC now owns 34,798 shares of the company worth $6,167,000 after acquiring 1,563 additional shares in the last quarter. Finally, Chemistry Wealth Management LLC purchased a new equity stake in Johnson & Johnson during the first quarter worth approximately $1,840,000. Institutional investors and hedge funds own 68.78% of the company’s shares.

Analysts set new price targets

A number of analysts have recently released reports on the company. Daiwa Capital Markets took over coverage from Johnson & Johnson in a Wednesday, June 22 research report. They set an “outperformance” rating on the stock. Citigroup lowered its price target on Johnson & Johnson from $205.00 to $201.00 in a Wednesday, July 20 research report. SVB Leerink lowered its price target on Johnson & Johnson from $200.00 to $194.00 in a Wednesday, July 20 report. StockNews.com upgraded Johnson & Johnson from a “buy” rating to a “strong buy” rating in a Tuesday, May 17 report. Finally, Credit Suisse Group raised its price target on Johnson & Johnson from $200.00 to $205.00 and gave the company an “outperform” rating in a Wednesday, April 20 report. Four equity research analysts gave the stock a hold rating, five gave the company a buy rating and one gave the company a high buy rating. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $189.89.

Johnson & Johnson Stock Performance

Shares of JNJ Stock opened at $170.18 on Wednesday. The company has a quick ratio of 1.17, a current ratio of 1.42 and a debt ratio of 0.37. The company has a 50-day moving average of $174.81 and a two-hundred-day moving average of $174.68. Johnson & Johnson has a 52-week low of $155.72 and a 52-week high of $186.69. The company has a market capitalization of $447.43 billion, a P/E ratio of 24.77, a PEG ratio of 3.25 and a beta of 0.59.

Johnson & Johnson (NYSE:JNJGet a rating) last released its results on Tuesday, July 19. The company reported EPS of $2.59 for the quarter, beating consensus analyst estimates of $2.57 by $0.02. Johnson & Johnson had a return on equity of 36.14% and a net margin of 19.21%. The company posted revenue of $24.02 billion in the quarter, versus a consensus estimate of $23.85 billion. During the same period a year earlier, the company posted earnings per share of $2.48. Johnson & Johnson’s quarterly revenue increased 3.0% from the same quarter last year. As a group, analysts expect Johnson & Johnson to post EPS of 10.05 for the current year.

Johnson & Johnson Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 6. Shareholders of record on Tuesday, August 23 will receive a dividend of $1.13 per share. The ex-dividend date is Monday, August 22. This represents an annualized dividend of $4.52 and a dividend yield of 2.66%. Johnson & Johnson’s dividend payout ratio is currently 65.79%.

Insider Trading at Johnson & Johnson

In other news, CAD Robert J. Decker sold 8,462 shares of the company in a transaction that took place on Thursday, May 26. The stock was sold at an average price of $180.00, for a total transaction of $1,523,160.00. Following completion of the transaction, the chief accounting officer now directly owns 15,473 shares of the company, valued at $2,785,140. The sale was disclosed in a legal filing with the SEC, accessible via this link. In other Johnson & Johnson news, Executive Vice President Kathryn E. Wengel sold 40,000 shares of the company in a deal that took place Friday, June 10. The stock was sold at an average price of $173.00, for a total value of $6,920,000.00. Following the completion of the sale, the executive vice president now directly owns 71,311 shares of the company, valued at $12,336,803. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, accessible via the SEC website. Additionally, CAO Robert J. Decker sold 8,462 shares of the company in a trade that took place on Thursday, May 26. The stock was sold at an average price of $180.00, for a total value of $1,523,160.00. Following the completion of the sale, the chief accounting officer now owns 15,473 shares of the company, valued at $2,785,140. Disclosure of this sale can be found here. Insiders own 0.35% of the shares of the company.

About Johnson & Johnson

(Get a rating)

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures and sells various healthcare products worldwide. The Company’s Consumer Health segment offers baby care products under the JOHNSON’S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the brands AVEENO, CLEAN & CLEAR, DR.

Featured articles

Institutional ownership by quarter for Johnson & Johnson (NYSE: JNJ)



Get news and reviews for Johnson & Johnson Daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for Johnson & Johnson and related companies with MarketBeat.com’s FREE daily newsletter.